Require electronic communication and remote computing service providers to report controlled substances violations, discovered via algorithms or human moderation, to the Attorney General. Specify duties, reporting, preservation, and penalties related to violations, excluding broadband and text messaging services.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the risk subdomain are described.
All other risk subdomains had no coverage in this document.
Risk Coverage Summary
This document has minimal coverage of AI risk domains. While it mentions algorithms and machine learning as detection methods for controlled substances violations (subsection (b)(1)(C) and (j)(5)), the document primarily addresses drug enforcement rather than AI-specific risks. There is no substantial coverage of AI safety, security vulnerabilities, governance failures, or other core AI risks defined in the MIT taxonomy.
Good coverage — Comprehensive governance measures or mitigations with clear procedures relating to the sector are explicitly described.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the sector are described.
All other sectors had no coverage in this document.
Sectors Summary
The document primarily governs the Information sector, specifically electronic communication service providers and remote computing services (with explicit exemptions for broadband internet access and text messaging services). These providers must report controlled substances violations discovered on their platforms to the Attorney General.
Hard Law
Legislative Status Summary
This is a binding federal statute enacted by the U.S. Congress with mandatory obligations ('shall'), criminal and civil penalties for non-compliance, and designated enforcement by the Attorney General.
Proposer
Target
Enforcer
Monitor
Lifecycle stages covered by the documents, as defined in the OECD Framework for the Classification of AI Systems
No lifecycle stages identified.
AI Lifecycle Summary
This document does not substantially address AI system lifecycle stages. It briefly acknowledges that controlled substances violations may be discovered through algorithms, machine learning, or other non-human methods, but does not govern AI development, training, validation, or deployment processes. The primary focus is on operational monitoring and reporting by service providers.
Terms relating to technical scope that are mentioned or implicitly referenced in the document
No technical scope terms identified.
Technical Scope Summary
The document makes minimal reference to AI technical scope. It mentions algorithms and machine learning only in the context of methods for discovering controlled substances violations (alongside human content moderation), requiring providers to report whether violations were discovered through human or non-human methods including algorithms and machine learning. No AI models, systems, or specific AI categories are defined or substantively addressed.
Document data from AGORA, CSET Emerging Technology Observatory.